首页 > 最新文献

BMB Reports最新文献

英文 中文
PDAT1 genome editing reduces hydroxy fatty acid production in transgenic Arabidopsis. PDAT1 基因组编辑减少了转基因拟南芥中羟基脂肪酸的产生。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Mid-Eum Park, Hyun Uk Kim

The fatty acids content of castor (Ricinus communis L.) seed oil is 80-90% ricinoleic acid, which is a hydroxy fatty acid (HFA). The structures and functional groups of HFAs are different from those of common fatty acids and are useful for various industrial applications. However, castor seeds contain the toxin ricin and an allergenic protein, which limit their cultivation. Accordingly, many researchers are conducting studies to enhance the production of HFAs in Arabidopsis thaliana, a model plant for oil crops. Oleate 12-hydroxylase from castor (RcFAH12), which synthesizes HFA (18:1-OH), was transformed into an Arabidopsis fae1 mutant, resulting in the CL37 line producing a maximum of 17% HFA content. In addition, castor phospholipid:diacylglycerol acyltransferase 1-2 (RcPDAT1-2), which catalyzes the production of triacylglycerol by transferring HFA from phosphatidylcholine to diacylglycerol, was transformed into the CL37 line to develop a P327 line that produces 25% HFA. In this study, we investigated changes in HFA content when endogenous Arabidopsis PDAT1 (AtPDAT1) of the P327 line was edited using the CRISPR/Cas9 technique. The successful mutation resulted in three independent lines with different mutation patterns, which were transmitted until the T4 generation. Fatty acid analysis of the seeds showed that HFA content decreased in all three mutant lines. These findings indicate that AtPDAT1 as well as RcPDAT1-2 in the P327 line are involved in transferring and increasing HFAs to triacylglycerol. [BMB Reports 2024; 57(2): 86-91].

蓖麻籽油(Ricinus communis L.)的脂肪酸含量为 80-90%,属于羟基脂肪酸(HFA)。羟基脂肪酸的结构和官能团与普通脂肪酸不同,可用于各种工业用途。然而,蓖麻籽含有毒素蓖麻毒素和一种致敏蛋白质,这限制了蓖麻籽的种植。因此,许多研究人员正在拟南芥(油料作物的模式植物)中开展研究,以提高氢脂肪酸的产量。将合成 HFA(18:1-OH)的蓖麻油酸 12-羟化酶(RcFAH12)转化到拟南芥 fae1 突变体中,结果 CL37 株系的 HFA 含量最高达到 17%。此外,我们还将蓖麻磷脂:二酰甘油酰基转移酶 1-2 (RcPDAT1-2)转化到 CL37 株系中,培育出能产生 25% HFA 的 P327 株系。在本研究中,我们研究了利用 CRISPR/Cas9 技术编辑 P327 株系的内源拟南芥 PDAT1(AtPDAT1)时 HFA 含量的变化。成功的突变产生了三个具有不同突变模式的独立品系,这些品系一直传至 T4 代。种子的脂肪酸分析表明,三个突变品系的 HFA 含量都有所下降。这些发现表明,P327品系中的AtPDAT1和RcPDAT1-2参与了氢氟烷烃向三酰甘油的转移和增加。
{"title":"PDAT1 genome editing reduces hydroxy fatty acid production in transgenic Arabidopsis.","authors":"Mid-Eum Park, Hyun Uk Kim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The fatty acids content of castor (Ricinus communis L.) seed oil is 80-90% ricinoleic acid, which is a hydroxy fatty acid (HFA). The structures and functional groups of HFAs are different from those of common fatty acids and are useful for various industrial applications. However, castor seeds contain the toxin ricin and an allergenic protein, which limit their cultivation. Accordingly, many researchers are conducting studies to enhance the production of HFAs in Arabidopsis thaliana, a model plant for oil crops. Oleate 12-hydroxylase from castor (RcFAH12), which synthesizes HFA (18:1-OH), was transformed into an Arabidopsis fae1 mutant, resulting in the CL37 line producing a maximum of 17% HFA content. In addition, castor phospholipid:diacylglycerol acyltransferase 1-2 (RcPDAT1-2), which catalyzes the production of triacylglycerol by transferring HFA from phosphatidylcholine to diacylglycerol, was transformed into the CL37 line to develop a P327 line that produces 25% HFA. In this study, we investigated changes in HFA content when endogenous Arabidopsis PDAT1 (AtPDAT1) of the P327 line was edited using the CRISPR/Cas9 technique. The successful mutation resulted in three independent lines with different mutation patterns, which were transmitted until the T4 generation. Fatty acid analysis of the seeds showed that HFA content decreased in all three mutant lines. These findings indicate that AtPDAT1 as well as RcPDAT1-2 in the P327 line are involved in transferring and increasing HFAs to triacylglycerol. [BMB Reports 2024; 57(2): 86-91].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"86-91"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138486671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction: Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway. 撤回:抑制 ClC-5 可通过 Wnt/β-catenin 信号通路抑制胆管癌细胞的增殖并诱导其凋亡。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Zhe Shi, Liyuan Zhou, Yan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An, Yanzhen Han

[Retraction to: BMB Rep. 2022 June 30; 55(6): 299-304.] Retraction: "Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway," by Zhe Shi, Liyuan Zhou, Yan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An and Yanzhen Han, BMB Rep. 2022; 55(6) 299-304: The above article, published online on 30 June 2022 in BMB Reports https://doi.org/10.5483/ BMBRep.2022.55.6.044), has been retracted by agreement between the authors and the journal's Editor in Chief. The authors unable to replicate certain results presented in the article and have therefore made the difficult decision to withdraw it. Editorial Board, BMB Reports.

[撤稿:BMB Rep. 2022年6月30日;55(6):299-304:"抑制ClC-5通过Wnt/β-catenin信号通路抑制胆管癌细胞增殖并诱导其凋亡》,作者:史哲、周丽媛、周艳、贾晓燕、于向军、安晓红、韩艳珍,BMB Rep. 2022; 55(6) 299-304:上述文章于2022年6月30日在线发表于《BMB Reports》https://doi.org/10.5483/ BMBRep.2022.55.6.044),经作者和期刊主编同意,已被撤稿。作者无法复制文章中的某些结果,因此做出了撤稿的艰难决定。BMB Reports 编辑委员会。
{"title":"Retraction: Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway.","authors":"Zhe Shi, Liyuan Zhou, Yan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An, Yanzhen Han","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>[Retraction to: BMB Rep. 2022 June 30; 55(6): 299-304.] Retraction: \"Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathway,\" by Zhe Shi, Liyuan Zhou, Yan Zhou, Xiaoyan Jia, Xiangjun Yu, Xiaohong An and Yanzhen Han, BMB Rep. 2022; 55(6) 299-304: The above article, published online on 30 June 2022 in BMB Reports https://doi.org/10.5483/ BMBRep.2022.55.6.044), has been retracted by agreement between the authors and the journal's Editor in Chief. The authors unable to replicate certain results presented in the article and have therefore made the difficult decision to withdraw it. Editorial Board, BMB Reports.</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":"57 2","pages":"123"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910095/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139982320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair. 肝脏 Sirt7 的缺失会损害 DNA 损伤修复,从而加速二乙基亚硝胺(DEN)诱导的肝细胞癌的形成。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Yuna Kim, Baeki E Kang, Karim Gariani, Joanna Gariani, Junguee Lee, Hyun-Jin Kim, Chang-Woo Lee, Kristina Schoonjans, Johan Auwerx, Dongryeol Ryu

The mammalian sirtuin family (SIRT1-SIRT7) has shown diverse biological roles in the regulation and maintenance of genome stability under genotoxic stress. SIRT7, one of the least studied sirtuin, has been demonstrated to be a key factor for DNA damage response (DDR). However, conflicting results have proposed that Sirt7 is an oncogenic factor to promote transformation in cancer cells. To address this inconsistency, we investigated properties of SIRT7 in hepatocellular carcinoma (HCC) regulation under DNA damage and found that loss of hepatic Sirt7 accelerated HCC progression. Specifically, the number, size, and volume of hepatic tumor colonies in diethylnitrosamine (DEN) injected Sirt7-deficient liver were markedly enhanced. Further, levels of HCC progression markers and pro-inflammatory cytokines were significantly elevated in the absence of hepatic Sirt7, unlike those in the control. In chromatin, SIRT7 was stabilized and colocalized to damage site by inhibiting the induction of γH2AX under DNA damage. Together, our findings suggest that SIRT7 is a crucial factor for DNA damage repair and that hepatic loss-of-Sirt7 can promote genomic instability and accelerate HCC development, unlike early studies describing that Sirt7 is an oncogenic factor [BMB Reports 2024; 57(2): 98-103].

哺乳动物 sirtuin 家族(SIRT1-SIRT7)在基因毒性胁迫下调节和维持基因组稳定性方面发挥了多种生物学作用。SIRT7是研究最少的sirtuin之一,已被证明是DNA损伤应答(DDR)的关键因素。然而,一些相互矛盾的结果认为 Sirt7 是促进癌细胞转化的致癌因子。为了解决这一矛盾,我们研究了SIRT7在肝癌(HCC)DNA损伤调控中的特性,发现肝脏Sirt7的缺失会加速HCC的进展。具体来说,在注射了二乙基亚硝胺(DEN)的Sirt7缺失肝脏中,肝肿瘤菌落的数量、大小和体积都明显增加。此外,与对照组不同,肝脏Sirt7缺失时,HCC进展标志物和促炎细胞因子的水平显著升高。在染色质中,SIRT7 通过抑制 DNA 损伤下 γH2AX 的诱导而稳定并定位在损伤位点上。总之,我们的研究结果表明,SIRT7是DNA损伤修复的关键因子,肝脏缺失Sirt7会促进基因组的不稳定性并加速HCC的发展,这与早期关于Sirt7是致癌因子的研究不同。
{"title":"Loss of hepatic Sirt7 accelerates diethylnitrosamine (DEN)-induced formation of hepatocellular carcinoma by impairing DNA damage repair.","authors":"Yuna Kim, Baeki E Kang, Karim Gariani, Joanna Gariani, Junguee Lee, Hyun-Jin Kim, Chang-Woo Lee, Kristina Schoonjans, Johan Auwerx, Dongryeol Ryu","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The mammalian sirtuin family (SIRT1-SIRT7) has shown diverse biological roles in the regulation and maintenance of genome stability under genotoxic stress. SIRT7, one of the least studied sirtuin, has been demonstrated to be a key factor for DNA damage response (DDR). However, conflicting results have proposed that Sirt7 is an oncogenic factor to promote transformation in cancer cells. To address this inconsistency, we investigated properties of SIRT7 in hepatocellular carcinoma (HCC) regulation under DNA damage and found that loss of hepatic Sirt7 accelerated HCC progression. Specifically, the number, size, and volume of hepatic tumor colonies in diethylnitrosamine (DEN) injected Sirt7-deficient liver were markedly enhanced. Further, levels of HCC progression markers and pro-inflammatory cytokines were significantly elevated in the absence of hepatic Sirt7, unlike those in the control. In chromatin, SIRT7 was stabilized and colocalized to damage site by inhibiting the induction of γH2AX under DNA damage. Together, our findings suggest that SIRT7 is a crucial factor for DNA damage repair and that hepatic loss-of-Sirt7 can promote genomic instability and accelerate HCC development, unlike early studies describing that Sirt7 is an oncogenic factor [BMB Reports 2024; 57(2): 98-103].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"98-103"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910089/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phenotypic characterization of pre-harvest sprouting resistance mutants generated by the CRISPR/Cas9-geminiviral replicon system in rice. 通过 CRISPR/Cas9 基因病毒复制子系统生成的水稻收获前萌芽抗性突变体的表型特征。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Jong Hee Kim, Jihyeon Yu, Jin Young Kim, Yong Jin Park, Sangsu Bae, Kwon Kyoo Kang, Yu Jin Jung

Pre-harvest sprouting is a critical phenomenon involving germination of seeds in the mother plant before harvest under relative humid conditions and reduced dormancy. In this paper, we generated HDR mutant lines with one region SNP (C/T) and an insertion of 6 bp (GGT/GGTGGCGGC) in OsERF1 genes for pre-harvest sprouting (PHS) resistance using CRISPR/Cas9 and a geminiviral replicon system. The incidence of HDR was 2.6% in transformed calli. T1 seeds were harvested from 12 HDR-induced calli and named ERF1-hdr line. Molecular stability, key agronomic properties, physiological properties, and biochemical properties of target genes in the ERF1-hdr line were investigated for three years. The ERF1-hdr line showed significantly enhanced seed dormancy and pre-harvest sprouting resistance. qRT-PCR analysis suggested that enhanced ABA signaling resulted in a stronger phenotype of PHS resistance. These results indicate that efficient HDR can be achieved through SNP/InDel replacement using a single and modular configuration applicable to different rice targets and other crops. This work demonstrates the potential to replace all genes with elite alleles within one generation and greatly expands our ability to improve agriculturally important traits. [BMB Reports 2024; 57(2): 79-85].

收获前萌发是一种关键现象,涉及种子在相对潮湿和休眠降低的条件下收获前在母株中的萌发。在本文中,我们利用 CRISPR/Cas9 和 geminiviral 复制子系统,在 OsERF1 基因中产生了一个区域 SNP(C/T)和一个插入 6 bp(GGT/GGTGGCGGC)的 HDR 突变株,以抗性收获前萌发(PHS)。在转化的胼胝体中,HDR 发生率为 2.6%。从 12 个 HDR 诱导的胼胝体中收获了 T1 种子,并将其命名为 ERF1-hdr 品系。对ERF1-hdr品系的分子稳定性、关键农艺特性、生理特性和目标基因的生化特性进行了为期三年的研究。qRT-PCR 分析表明,ABA 信号的增强导致了更强的 PHS 抗性表型。这些结果表明,利用适用于不同水稻目标和其他作物的单一模块化配置,可以通过 SNP/InDel 替换实现高效 HDR。这项工作证明了在一代人的时间内用精英等位基因替换所有基因的潜力,并极大地扩展了我们改良重要农业性状的能力。
{"title":"Phenotypic characterization of pre-harvest sprouting resistance mutants generated by the CRISPR/Cas9-geminiviral replicon system in rice.","authors":"Jong Hee Kim, Jihyeon Yu, Jin Young Kim, Yong Jin Park, Sangsu Bae, Kwon Kyoo Kang, Yu Jin Jung","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Pre-harvest sprouting is a critical phenomenon involving germination of seeds in the mother plant before harvest under relative humid conditions and reduced dormancy. In this paper, we generated HDR mutant lines with one region SNP (C/T) and an insertion of 6 bp (GGT/GGTGGCGGC) in OsERF1 genes for pre-harvest sprouting (PHS) resistance using CRISPR/Cas9 and a geminiviral replicon system. The incidence of HDR was 2.6% in transformed calli. T1 seeds were harvested from 12 HDR-induced calli and named ERF1-hdr line. Molecular stability, key agronomic properties, physiological properties, and biochemical properties of target genes in the ERF1-hdr line were investigated for three years. The ERF1-hdr line showed significantly enhanced seed dormancy and pre-harvest sprouting resistance. qRT-PCR analysis suggested that enhanced ABA signaling resulted in a stronger phenotype of PHS resistance. These results indicate that efficient HDR can be achieved through SNP/InDel replacement using a single and modular configuration applicable to different rice targets and other crops. This work demonstrates the potential to replace all genes with elite alleles within one generation and greatly expands our ability to improve agriculturally important traits. [BMB Reports 2024; 57(2): 79-85].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"79-85"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on hydrogel-based drug therapy in melanoma immunotherapy. 水凝胶药物疗法在黑色素瘤免疫疗法中的研究进展。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Wei He, Yanqin Zhang, Yi Qu, Mengmeng Liu, Guodong Li, Luxiang Pan, Xinyao Xu, Gege Shi, Qiang Hao, Fen Liu, Yuan Gao

Melanoma is one of the most aggressive skin tumors, and conventional treatment modalities are not effective in treating advanced melanoma. Although immunotherapy is an effective treatment for melanoma, it has disadvantages, such as a poor response rate and serious systemic immune-related toxic side effects. The main solution to this problem is the use of biological materials such as hydrogels to reduce these side effects and amplify the immune killing effect against tumor cells. Hydrogels have great advantages as local slow-release drug carriers, including the ability to deliver antitumor drugs directly to the tumor site, enhance the local drug concentration in tumor tissue, reduce systemic drug distribution and exhibit good degradability. Despite these advantages, there has been limited research on the application of hydrogels in melanoma treatment. Therefore, this article provides a comprehensive review of the potential application of hydrogels in melanoma immunotherapy. Hydrogels can serve as carriers for sustained drug delivery, enabling the targeted and localized delivery of drugs with minimal systemic side effects. This approach has the potential to improve the efficacy of immunotherapy for melanoma. Thus, the use of hydrogels as drug delivery vehicles for melanoma immunotherapy has great potential and warrants further exploration. [BMB Reports 2024; 57(2): 71-78].

黑色素瘤是侵袭性最强的皮肤肿瘤之一,传统治疗方法对治疗晚期黑色素瘤效果不佳。虽然免疫疗法是治疗黑色素瘤的有效方法,但它也有缺点,如反应率低和严重的全身免疫相关毒副作用。解决这一问题的主要办法是使用水凝胶等生物材料来减少这些副作用,并增强对肿瘤细胞的免疫杀伤效果。水凝胶作为局部缓释药物载体具有很大的优势,包括能够将抗肿瘤药物直接输送到肿瘤部位,提高肿瘤组织中的局部药物浓度,减少全身药物分布,并表现出良好的降解性。尽管水凝胶具有这些优点,但目前有关其在黑色素瘤治疗中应用的研究还很有限。因此,本文全面综述了水凝胶在黑色素瘤免疫疗法中的潜在应用。水凝胶可作为持续给药的载体,实现药物的靶向和局部给药,同时将全身副作用降至最低。这种方法有可能提高黑色素瘤免疫疗法的疗效。因此,使用水凝胶作为黑色素瘤免疫疗法的给药载体具有巨大的潜力,值得进一步探索。
{"title":"Research progress on hydrogel-based drug therapy in melanoma immunotherapy.","authors":"Wei He, Yanqin Zhang, Yi Qu, Mengmeng Liu, Guodong Li, Luxiang Pan, Xinyao Xu, Gege Shi, Qiang Hao, Fen Liu, Yuan Gao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Melanoma is one of the most aggressive skin tumors, and conventional treatment modalities are not effective in treating advanced melanoma. Although immunotherapy is an effective treatment for melanoma, it has disadvantages, such as a poor response rate and serious systemic immune-related toxic side effects. The main solution to this problem is the use of biological materials such as hydrogels to reduce these side effects and amplify the immune killing effect against tumor cells. Hydrogels have great advantages as local slow-release drug carriers, including the ability to deliver antitumor drugs directly to the tumor site, enhance the local drug concentration in tumor tissue, reduce systemic drug distribution and exhibit good degradability. Despite these advantages, there has been limited research on the application of hydrogels in melanoma treatment. Therefore, this article provides a comprehensive review of the potential application of hydrogels in melanoma immunotherapy. Hydrogels can serve as carriers for sustained drug delivery, enabling the targeted and localized delivery of drugs with minimal systemic side effects. This approach has the potential to improve the efficacy of immunotherapy for melanoma. Thus, the use of hydrogels as drug delivery vehicles for melanoma immunotherapy has great potential and warrants further exploration. [BMB Reports 2024; 57(2): 71-78].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"71-78"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910090/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138486674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer. 韩国结直肠癌患者的 DNA 甲基化综合分析。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Hyeran Shim, Kiwon Jang, Yeong Hak Bang, Hoang Bao Khanh Chu, Jisun Kang, Jin-Young Lee, Sheehyun Cho, Hong Seok Lee, Jongbum Jeon, Taeyeon Hwang, Soobok Joe, Jinyeong Lim, Ji-Hye Choi, Eun Hye Joo, Kyunghee Park, Ji Hwan Moon, Kyung Yeon Han, Yourae Hong, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Yoon Ah Park, Jung Wook Huh, Jung Kyong Shin, Dae Hee Pyo, Hyekyung Hong, Hae-Ock Lee, Woong-Yang Park, Jin Ok Yang, Young-Joon Kim

Alterations in DNA methylation play an important pathophysiological role in the development and progression of colorectal cancer. We comprehensively profiled DNA methylation alterations in 165 Korean patients with colorectal cancer (CRC), and conducted an in-depth investigation of cancer-specific methylation patterns. Our analysis of the tumor samples revealed a significant presence of hypomethylated probes, primarily within the gene body regions; few hypermethylated sites were observed, which were mostly enriched in promoter-like and CpG island regions. The CpG Island Methylator PhenotypeHigh (CIMP-H) exhibited notable enrichment of microsatellite instability-high (MSI-H). Additionally, our findings indicated a significant correlation between methylation of the MLH1 gene and MSI-H status. Furthermore, we found that the CIMP-H had a higher tendency to affect the right-side of the colon tissues and was slightly more prevalent among older patients. Through our methylome profile analysis, we successfully verified the thylation patterns and clinical characteristics of Korean patients with CRC. This valuable dataset lays a strong foundation for exploring novel molecular insights and potential therapeutic targets for the treatment of CRC. [BMB Reports 2024; 57(2): 110-115].

DNA 甲基化的改变在结直肠癌的发生和发展过程中起着重要的病理生理作用。我们全面分析了 165 名韩国结直肠癌(CRC)患者的 DNA 甲基化改变,并对癌症特异性甲基化模式进行了深入研究。我们对肿瘤样本的分析表明,存在大量的低甲基化探针,主要集中在基因体区域;观察到的高甲基化位点很少,主要富集在启动子样区域和 CpG 岛区域。CpG 岛甲基化表型高(CIMP-H)表现出明显的微卫星不稳定性高(MSI-H)富集。此外,我们的研究结果表明,MLH1 基因的甲基化与 MSI-H 状态之间存在显著相关性。此外,我们还发现,CIMP-H 更倾向于影响结肠右侧组织,而且在老年患者中发病率略高。通过甲基组图谱分析,我们成功验证了韩国 CRC 患者的甲基化模式和临床特征。这一宝贵的数据集为探索治疗 CRC 的新分子见解和潜在治疗靶点奠定了坚实的基础。[BMB Reports 2024; 57(2): 110-115].
{"title":"Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer.","authors":"Hyeran Shim, Kiwon Jang, Yeong Hak Bang, Hoang Bao Khanh Chu, Jisun Kang, Jin-Young Lee, Sheehyun Cho, Hong Seok Lee, Jongbum Jeon, Taeyeon Hwang, Soobok Joe, Jinyeong Lim, Ji-Hye Choi, Eun Hye Joo, Kyunghee Park, Ji Hwan Moon, Kyung Yeon Han, Yourae Hong, Woo Yong Lee, Hee Cheol Kim, Seong Hyeon Yun, Yong Beom Cho, Yoon Ah Park, Jung Wook Huh, Jung Kyong Shin, Dae Hee Pyo, Hyekyung Hong, Hae-Ock Lee, Woong-Yang Park, Jin Ok Yang, Young-Joon Kim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Alterations in DNA methylation play an important pathophysiological role in the development and progression of colorectal cancer. We comprehensively profiled DNA methylation alterations in 165 Korean patients with colorectal cancer (CRC), and conducted an in-depth investigation of cancer-specific methylation patterns. Our analysis of the tumor samples revealed a significant presence of hypomethylated probes, primarily within the gene body regions; few hypermethylated sites were observed, which were mostly enriched in promoter-like and CpG island regions. The CpG Island Methylator PhenotypeHigh (CIMP-H) exhibited notable enrichment of microsatellite instability-high (MSI-H). Additionally, our findings indicated a significant correlation between methylation of the MLH1 gene and MSI-H status. Furthermore, we found that the CIMP-H had a higher tendency to affect the right-side of the colon tissues and was slightly more prevalent among older patients. Through our methylome profile analysis, we successfully verified the thylation patterns and clinical characteristics of Korean patients with CRC. This valuable dataset lays a strong foundation for exploring novel molecular insights and potential therapeutic targets for the treatment of CRC. [BMB Reports 2024; 57(2): 110-115].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"110-115"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10414456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic potential of BMSC-conditioned medium in an in vitro model of renal fibrosis using the RPTEC/TERT1 cell line. 在使用 RPTEC/TERT1 细胞系的肾脏纤维化体外模型中,BMSC 调节培养基的治疗潜力。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Yunji Kim, Dayeon Kang, Ga-Eun Choi, Sang Dae Kim, Sun-Ja Yang, Hyosang Kim, Dalsan You, Choung Soo Kim, Nayoung Suh

We investigated the therapeutic potential of bone marrow-derived mesenchymal stem cell-conditioned medium (BMSC-CM) on immortalized renal proximal tubule epithelial cells (RPTEC/ TERT1) in a fibrotic environment. To replicate the increased stiffness characteristic of kidneys in chronic kidney disease, we utilized polyacrylamide gel platforms. A stiff matrix was shown to increase α-smooth muscle actin (α-SMA) levels, indicating fibrogenic activation in RPTEC/TERT1 cells. Interestingly, treatment with BMSC-CM resulted in significant reductions in the levels of fibrotic markers (α-SMA and vimentin) and increases in the levels of the epithelial marker E-cadherin and aquaporin 7, particularly under stiff conditions. Furthermore, BMSC-CM modified microRNA (miRNA) expression and reduced oxidative stress levels in these cells. Our findings suggest that BMSC-CM can modulate cellular morphology, miRNA expression, and oxidative stress in RPTEC/TERT1 cells, highlighting its therapeutic potential in fibrotic kidney disease. [BMB Reports 2024; 57(2): 116-121].

我们研究了骨髓间充质干细胞调节培养基(BMSC-CM)在纤维化环境中对永生化肾近曲小管上皮细胞(RPTEC/ TERT1)的治疗潜力。为了复制慢性肾病患者肾脏特有的硬度增加现象,我们使用了聚丙烯酰胺凝胶平台。结果表明,僵硬的基质会增加α-平滑肌肌动蛋白(α-SMA)的水平,这表明RPTEC/TERT1细胞发生了纤维化活化。有趣的是,用 BMSC-CM 处理后,纤维化标记物(α-SMA 和波形蛋白)的水平明显降低,而上皮标记物 E-cadherin 和 aquaporin 7 的水平则升高,尤其是在僵硬条件下。此外,BMSC-CM 还能改变微核糖核酸(miRNA)的表达,降低这些细胞的氧化应激水平。我们的研究结果表明,BMSC-CM 可调节 RPTEC/TERT1 细胞的细胞形态、miRNA 表达和氧化应激,突出了其在纤维化肾病中的治疗潜力。
{"title":"Therapeutic potential of BMSC-conditioned medium in an in vitro model of renal fibrosis using the RPTEC/TERT1 cell line.","authors":"Yunji Kim, Dayeon Kang, Ga-Eun Choi, Sang Dae Kim, Sun-Ja Yang, Hyosang Kim, Dalsan You, Choung Soo Kim, Nayoung Suh","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We investigated the therapeutic potential of bone marrow-derived mesenchymal stem cell-conditioned medium (BMSC-CM) on immortalized renal proximal tubule epithelial cells (RPTEC/ TERT1) in a fibrotic environment. To replicate the increased stiffness characteristic of kidneys in chronic kidney disease, we utilized polyacrylamide gel platforms. A stiff matrix was shown to increase α-smooth muscle actin (α-SMA) levels, indicating fibrogenic activation in RPTEC/TERT1 cells. Interestingly, treatment with BMSC-CM resulted in significant reductions in the levels of fibrotic markers (α-SMA and vimentin) and increases in the levels of the epithelial marker E-cadherin and aquaporin 7, particularly under stiff conditions. Furthermore, BMSC-CM modified microRNA (miRNA) expression and reduced oxidative stress levels in these cells. Our findings suggest that BMSC-CM can modulate cellular morphology, miRNA expression, and oxidative stress in RPTEC/TERT1 cells, highlighting its therapeutic potential in fibrotic kidney disease. [BMB Reports 2024; 57(2): 116-121].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"116-121"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gefitinib induces anoikis in cervical cancer cells. 吉非替尼能诱导宫颈癌细胞发生厌氧反应。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-01
Byung Chul Jung, Sung-Hun Woo, Sung Hoon Kim, Yoon Suk Kim

Gefitinib exerts anticancer effects on various types of cancer, such as lung, ovarian, breast, and colon cancers. However, the therapeutic effects of gefitinib on cervical cancer and the underlying mechanisms remain unclear. Thus, this study aimed to explore whether gefitinib can be used to treat cervical cancer and elucidate the underlying mechanisms. Results showed that gefitinib induced a caspase-dependent apoptosis of HeLa cells, which consequently became round and detached from the surface of the culture plate. Gefitinib induced the reorganization of actin cytoskeleton and downregulated the expression of p-FAK, integrin β1 and E-cadherin, which are important in cell-extracellular matrix adhesion and cell-cell interaction, respectively. Moreover, gefitinib hindered cell reattachment and spreading and suppressed interactions between detached cells in suspension, leading to poly (ADP-ribose) polymerase cleavage, a hallmark of apoptosis. It also induced detachment-induced apoptosis (anoikis) in C33A cells, another cervical cancer cell line. Taken together, these results suggest that gefitinib triggers anoikis in cervical cancer cells. Our findings may serve as a basis for broadening the range of anticancer drugs used to treat cervical cancer. [BMB Reports 2024; 57(2): 104-109].

吉非替尼对肺癌、卵巢癌、乳腺癌和结肠癌等多种癌症具有抗癌作用。然而,吉非替尼对宫颈癌的治疗效果及其内在机制仍不清楚。因此,本研究旨在探讨吉非替尼是否可用于治疗宫颈癌,并阐明其潜在机制。结果显示,吉非替尼能诱导卡巴酶依赖性的HeLa细胞凋亡,从而使细胞变圆并脱离培养板表面。吉非替尼诱导肌动蛋白细胞骨架的重组,并下调p-FAK、整合素β1和E-cadherin的表达,而这三种蛋白分别在细胞-细胞外基质粘附和细胞-细胞相互作用中起重要作用。此外,吉非替尼阻碍了细胞的再粘附和扩散,抑制了悬浮液中脱落细胞之间的相互作用,导致聚(ADP-核糖)聚合酶裂解,这是细胞凋亡的标志。它还能诱导另一种宫颈癌细胞系 C33A 细胞发生脱落诱导凋亡(anoikis)。综上所述,这些结果表明吉非替尼会引发宫颈癌细胞的anoikis。我们的研究结果可作为扩大用于治疗宫颈癌的抗癌药物范围的依据。
{"title":"Gefitinib induces anoikis in cervical cancer cells.","authors":"Byung Chul Jung, Sung-Hun Woo, Sung Hoon Kim, Yoon Suk Kim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gefitinib exerts anticancer effects on various types of cancer, such as lung, ovarian, breast, and colon cancers. However, the therapeutic effects of gefitinib on cervical cancer and the underlying mechanisms remain unclear. Thus, this study aimed to explore whether gefitinib can be used to treat cervical cancer and elucidate the underlying mechanisms. Results showed that gefitinib induced a caspase-dependent apoptosis of HeLa cells, which consequently became round and detached from the surface of the culture plate. Gefitinib induced the reorganization of actin cytoskeleton and downregulated the expression of p-FAK, integrin β1 and E-cadherin, which are important in cell-extracellular matrix adhesion and cell-cell interaction, respectively. Moreover, gefitinib hindered cell reattachment and spreading and suppressed interactions between detached cells in suspension, leading to poly (ADP-ribose) polymerase cleavage, a hallmark of apoptosis. It also induced detachment-induced apoptosis (anoikis) in C33A cells, another cervical cancer cell line. Taken together, these results suggest that gefitinib triggers anoikis in cervical cancer cells. Our findings may serve as a basis for broadening the range of anticancer drugs used to treat cervical cancer. [BMB Reports 2024; 57(2): 104-109].</p>","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":" ","pages":"104-109"},"PeriodicalIF":3.8,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10910092/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139671150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Applications of CRISPR technologies to the development of gene and cell therapy. 将 CRISPR 技术应用于基因和细胞疗法的开发。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-01-04 DOI: 10.5483/bmbrep.2023-0221
Chul-Sung Park, Omer Habib, Younsu Lee, J. Hur
Advancements in gene and cell therapy have resulted in novel therapeutics for diseases previously considered incurable or challenging to treat. Among the various contributing technologies, genome editing stands out as one of the most crucial for the progress in gene and cell therapy. The discovery of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and the subsequent evolution of genetic engineering technology have markedly expanded the field of target-specific gene editing. Originally studied in the immune systems of bacteria and archaea, the CRISPR system has demonstrated wide applicability to effective genome editing of various biological systems including human cells. The development of CRISPR-based base editing has enabled directional cytosine-tothymine and adenine-to-guanine substitutions of select DNA bases at the target locus. Subsequent advances in prime editing further elevated the flexibility of the edit multiple consecutive bases to desired sequences. The recent CRISPR technologies also have been actively utilized for the development of in vivo and ex vivo gene and cell therapies. We anticipate that the medical applications of CRISPR will rapidly progress to provide unprecedented possibilities to develop novel therapeutics towards various diseases.
基因和细胞疗法的进步为以前被认为无法治愈或难以治疗的疾病带来了新的疗法。在各种促进技术中,基因组编辑技术是基因和细胞疗法取得进展的最关键技术之一。CRISPR(Clustered Regularly Interspaced Short Palindromic Repeats)的发现以及随后基因工程技术的发展,极大地拓展了靶向基因编辑领域。CRISPR 系统最初是在细菌和古细菌的免疫系统中进行研究的,现已广泛应用于包括人类细胞在内的各种生物系统的有效基因组编辑。基于 CRISPR 的碱基编辑技术的发展实现了目标基因座上特定 DNA 碱基的胞嘧啶-胸腺嘧啶和腺嘌呤-鸟嘌呤定向替换。随后的素材编辑技术进一步提高了将多个连续碱基编辑为所需序列的灵活性。最近,CRISPR 技术还被积极用于体内和体外基因和细胞疗法的开发。我们预计,CRISPR 的医学应用将迅速发展,为开发针对各种疾病的新型疗法提供前所未有的可能性。
{"title":"Applications of CRISPR technologies to the development of gene and cell therapy.","authors":"Chul-Sung Park, Omer Habib, Younsu Lee, J. Hur","doi":"10.5483/bmbrep.2023-0221","DOIUrl":"https://doi.org/10.5483/bmbrep.2023-0221","url":null,"abstract":"Advancements in gene and cell therapy have resulted in novel therapeutics for diseases previously considered incurable or challenging to treat. Among the various contributing technologies, genome editing stands out as one of the most crucial for the progress in gene and cell therapy. The discovery of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and the subsequent evolution of genetic engineering technology have markedly expanded the field of target-specific gene editing. Originally studied in the immune systems of bacteria and archaea, the CRISPR system has demonstrated wide applicability to effective genome editing of various biological systems including human cells. The development of CRISPR-based base editing has enabled directional cytosine-tothymine and adenine-to-guanine substitutions of select DNA bases at the target locus. Subsequent advances in prime editing further elevated the flexibility of the edit multiple consecutive bases to desired sequences. The recent CRISPR technologies also have been actively utilized for the development of in vivo and ex vivo gene and cell therapies. We anticipate that the medical applications of CRISPR will rapidly progress to provide unprecedented possibilities to develop novel therapeutics towards various diseases.","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":"33 17","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139385208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current status of genome editing technologies: special issue of BMB Reports in 2024. 基因组编辑技术的现状:2024 年 BMB 报告特刊。
IF 3.8 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-01-04 DOI: 10.5483/bmbrep.2023-0248
Ju-Chan Park, Sangsu Bae
Since the identification of DNA as a genetic material, manipulating DNA in various organisms has been a long standing dream of humanity. In pursuit of this objective, technologies to edit genome have been extensively developed over the recent decades. The emergence of zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems enabled site-specific DNA cleavage in a programmable manner. Furthermore, the advent of base editors (BEs) and prime editors (PEs) has enabled base conversion and insertion/deletion with a high accuracy. In addition to the editing of genomic DNA in the nucleus, attempts to manipulate circular DNAs in organelle are currently ongoing. These technologies are bringing major progress in diverse fields including the engineering of cells, livestock, and plants as well as therapeutic gene correction in humans. In this special issue, we aim to cover the recent advances in genome editing technology and its applications in therapeutics, breed improvement in plants and livestock, RNA recording, and protein evolution.
自从 DNA 被确认为遗传物质以来,操纵各种生物的 DNA 一直是人类的夙愿。为了实现这一目标,近几十年来基因组编辑技术得到了广泛的发展。锌指核酸酶(ZFN)、转录激活剂样效应核酸酶(TALEN)、簇状规则间隔短回文重复序列(CRISPR)和CRISPR相关(Cas)系统的出现,实现了以可编程的方式定点切割DNA。此外,碱基编辑器(BE)和质粒编辑器(PE)的出现也实现了高精度的碱基转换和插入/删除。除了编辑细胞核中的基因组 DNA 外,目前还在尝试操纵细胞器中的环状 DNA。这些技术在多个领域都取得了重大进展,包括细胞、牲畜和植物工程以及人类治疗性基因矫正。本特刊旨在介绍基因组编辑技术的最新进展及其在治疗、植物和家畜品种改良、RNA记录和蛋白质进化方面的应用。
{"title":"Current status of genome editing technologies: special issue of BMB Reports in 2024.","authors":"Ju-Chan Park, Sangsu Bae","doi":"10.5483/bmbrep.2023-0248","DOIUrl":"https://doi.org/10.5483/bmbrep.2023-0248","url":null,"abstract":"Since the identification of DNA as a genetic material, manipulating DNA in various organisms has been a long standing dream of humanity. In pursuit of this objective, technologies to edit genome have been extensively developed over the recent decades. The emergence of zinc finger nuclease (ZFN), transcription activator-like effector nuclease (TALEN), and clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) systems enabled site-specific DNA cleavage in a programmable manner. Furthermore, the advent of base editors (BEs) and prime editors (PEs) has enabled base conversion and insertion/deletion with a high accuracy. In addition to the editing of genomic DNA in the nucleus, attempts to manipulate circular DNAs in organelle are currently ongoing. These technologies are bringing major progress in diverse fields including the engineering of cells, livestock, and plants as well as therapeutic gene correction in humans. In this special issue, we aim to cover the recent advances in genome editing technology and its applications in therapeutics, breed improvement in plants and livestock, RNA recording, and protein evolution.","PeriodicalId":9010,"journal":{"name":"BMB Reports","volume":"11 12","pages":""},"PeriodicalIF":3.8,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139385269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMB Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1